循環器ジャーナル66巻2号

2018年04月発行

特集 Structural Heart Diseaseインターベンション—「新しい」インターベンションのすべて Ⅲ．先天性，その他

経カテーテル人工弁周囲逆流閉鎖術の適応と実際

著者： 有田武史¹

所属機関： ¹九州大学病院血液・腫瘍・心血管内科

ページ範囲：P.274 - P.281

Point
・溶血性貧血や心不全を来した人工弁周囲逆流に対する治療は，外科的再手術のほかに近年では経カテーテル人工弁周囲逆流閉鎖術が行われるようになっている．
・経カテーテル人工弁周囲逆流閉鎖術は人工弁周囲逆流の位置によっていろいろなアプローチのしかたがある．
・経カテーテル人工弁周囲逆流に用いられるデバイスはほとんどオフラベルデバイスであり，今後のさらなる専用デバイスの開発が求められる．

参考文献

1) Rihal CS, Sorajja P, Booker JD, et al:Principles of percutaneous paravalvular leak closure. JACC Cardiovasc Interv 5:121-130, 2012

2) Ionescu A, Fraser AG, Butchart EG:Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation:a prospective study using transoesophageal echocardiography. Heart 89:1316-1321, 2003

3) Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P:Natural history of early aortic paraprosthetic regurgitation:a five-year follow-up. Am Heart J 138:351-357, 1999

4) Ruiz CE, Hahn RT, Berrebi A, et al:Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis:An Expert Statement. J Am Coll Cardiol 69:2067-2087, 2017

5) Kappetein AP, Head SJ, Généreux P, et al:Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation. J Am Coll Cardiol 60:1438-1454, 2012

6) Arribas-Jimenez A, Rama-Merchan JC, Barreiro-Pérez M, et al:Utility of Real-Time 3-Dimensional Transesophageal Echocardiography in the Assessment of Mitral Paravalvular Leak. Circ J 80:738-744, 2016

7) Aoyagi S, Fukunaga S, Tayama E, et al:Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage. Asian Cardiovasc Thorac Ann 15:441-443, 2007

8) Desai PA, Tafreshi J, Pai RG:Beta-blocker therapy for valvular disorders. J Heart Valve Dis 20:241-253, 2011

9) Cho IJ, Hong GR, Lee S, et al:Predictors of prognosis in patients with mild to moderate paravalvular leakage after mitral valve replacement. J Card Surg 29:149-154, 2014

10) García E, Sandoval J, Unzue L, et al:Paravalvular leaks:mechanisms, diagnosis and management. EuroIntervention 8 Suppl Q:41-52, 2012

11) Taramasso M, Maisano F, Denti P, et al:Surgical treatment of paravalvular leak:Long-term results in a single-center experience（up to 14 years）. J Thorac Cardiovasc Surg 149:1270-1275, 2015

12) Baumgartner H, Falk V, Bax JJ, et al:2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739-2786, 2017

13) Nishimura RA, Otto CM, Bonow RO, et al:2014 AHA/ACC guideline for the management of patients with valvular heart disease:A report of the american college of cardiology/american heart association task force on practice guidelines. Circulation 129:e521-643, 2014

14) Taramasso M, Maisano F, Latib A, et al:Conventional surgery and transcatheter closure via surgical transapical approach for paravalvular leak repair in high-risk patients:results from a single-centre experience. Eur Heart J Cardiovasc Imaging 15:1161-1167, 2014

15) Wells IV JA, Condado JF, Kamioka N, et al:Outcomes After Paravalvular Leak Closure. JACC Cardiovasc Interv 10:500-507, 2017

16) Hourihan M, Perry SB, Mandell VS, et al:Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol 20:1371-1377, 1992

17) Sorajja P, Cabalka AK, Hagler DJ, Rihal CS:Percutaneous repair of paravalvular prosthetic regurgitation:Acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv 4:314-321, 2011

18) Millán X, Skaf S, Joseph L, et al:Transcatheter Reduction of Paravalvular Leaks:A Systematic Review and Meta-analysis. Can J Cardiol 31:260-269, 2015